Javascript must be enabled to continue!
NAD + capping of RNA in Archaea and Mycobacteria
View through CrossRef
ABSTRACT
Chemical modifications of RNA affect essential properties of transcripts, such as their translation, localization and stability. 5’-end RNA capping with the ubiquitous redox cofactor nicotinamide adenine dinucleotide (NAD
+
) has been discovered in organisms ranging from bacteria to mammals. However, the hypothesis that NAD
+
capping might be universal in all domains of life has not been proven yet, as information on this RNA modification is missing for Archaea. Likewise, this RNA modification has not been studied in the clinically important
Mycobacterium
genus. Here, we demonstrate that NAD
+
capping occurs in the archaeal and mycobacterial model organisms
Methanosarcina barkeri
and
Mycobacterium smegmatis.
Moreover, we identify the NAD
+
-capped transcripts in
M. smegmatis,
showing that this modification is more prevalent in stationary phase, and revealing that mycobacterial NAD
+
-capped transcripts include non-coding small RNAs, such as Ms1. Furthermore, we show that mycobacterial RNA polymerase incorporates NAD
+
into RNA, and that the genes of NAD
+
-capped transcripts are preceded by promoter elements compatible with σ
A
/σ
F
dependent expression. Taken together, our findings demonstrate that NAD
+
capping exists in the archaeal domain of life, suggesting that it is universal to all living organisms, and define the NAD
+
-capped RNA landscape in mycobacteria, providing a basis for its future exploration.
Title: NAD
+
capping of RNA in Archaea and Mycobacteria
Description:
ABSTRACT
Chemical modifications of RNA affect essential properties of transcripts, such as their translation, localization and stability.
5’-end RNA capping with the ubiquitous redox cofactor nicotinamide adenine dinucleotide (NAD
+
) has been discovered in organisms ranging from bacteria to mammals.
However, the hypothesis that NAD
+
capping might be universal in all domains of life has not been proven yet, as information on this RNA modification is missing for Archaea.
Likewise, this RNA modification has not been studied in the clinically important
Mycobacterium
genus.
Here, we demonstrate that NAD
+
capping occurs in the archaeal and mycobacterial model organisms
Methanosarcina barkeri
and
Mycobacterium smegmatis.
Moreover, we identify the NAD
+
-capped transcripts in
M.
smegmatis,
showing that this modification is more prevalent in stationary phase, and revealing that mycobacterial NAD
+
-capped transcripts include non-coding small RNAs, such as Ms1.
Furthermore, we show that mycobacterial RNA polymerase incorporates NAD
+
into RNA, and that the genes of NAD
+
-capped transcripts are preceded by promoter elements compatible with σ
A
/σ
F
dependent expression.
Taken together, our findings demonstrate that NAD
+
capping exists in the archaeal domain of life, suggesting that it is universal to all living organisms, and define the NAD
+
-capped RNA landscape in mycobacteria, providing a basis for its future exploration.
Related Results
Sex-related differences in human plasma NAD+/NADH levels depend on age
Sex-related differences in human plasma NAD+/NADH levels depend on age
Abstract
Nicotinamide adenine dinucleotide (NAD) is a coenzyme in metabolic reactions and cosubstrate in signaling pathways of cells. While the intracellular functio...
HIV–1 infection reduces NAD capping of host cell snRNA and snoRNA
HIV–1 infection reduces NAD capping of host cell snRNA and snoRNA
Abstract
Nicotinamide adenine dinucleotide (NAD) is a critical component of the cellular metabolism and also serves as an alternative 5′ cap on various RNAs. Howeve...
Elevation of NAD+ by nicotinamide riboside spares spinal cord tissue from injury and promotes locomotor recovery
Elevation of NAD+ by nicotinamide riboside spares spinal cord tissue from injury and promotes locomotor recovery
ABSTRACTSpinal cord injury (SCI)-induced tissue damage spreads to neighboring spared cells in the hours, days and weeks following injury leading to exacerbation of tissue damage an...
HIV-1 infection reduces NAD capping of host cell snRNA and snoRNA
HIV-1 infection reduces NAD capping of host cell snRNA and snoRNA
Abstract
NAD is a key component of cellular metabolism and also serves as an alternative 5’cap on short noncoding RNAs. The function of NAD in RNA, however, remains poorly ...
B-247 BLADE-R: streamlined RNA extraction for clinical diagnostics and high-throughput applications
B-247 BLADE-R: streamlined RNA extraction for clinical diagnostics and high-throughput applications
Abstract
Background
Efficient nucleic acid extraction and purification are crucial for cellular and molecular biology research, ...
Xrn1 is a deNADding Enzyme Modulating Mitochondrial NAD Levels
Xrn1 is a deNADding Enzyme Modulating Mitochondrial NAD Levels
ABSTRACTThe existence of non-canonical nicotinamide adenine diphosphate (NAD) 5’-end capped RNAs is now well established. Nevertheless, the biological function of this nucleotide m...
Detection of Multiple Types of Cancer Driver Mutations Using Targeted RNA Sequencing in NSCLC
Detection of Multiple Types of Cancer Driver Mutations Using Targeted RNA Sequencing in NSCLC
ABSTRACTCurrently, DNA and RNA are used separately to capture different types of gene mutations. DNA is commonly used for the detection of SNVs, indels and CNVs; RNA is used for an...

